Expression of the p38 MAPK, NF-κB and cyclin D1 in extramammary Paget's disease

Journal of Dermatological Science

Volumn 45, Issue 3, 2007, Pages 187-192

  Lin, Nengxing ^a,b   Uchi, Hiroshi ^a   Moroi, Yoichi ^a   Fukiwake, Noriko ^a   Dainichi, Teruki ^a   Takeuchi, Satoshi ^a   Takahara, Masakazu ^a   Tu, Yating ^b   Furue, Masutaka ^a   Urabe, Kazunori ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cyclin D1; EMPD; NF B; p38 MAPKs

Indexed keywords

CYCLIN D1; FORMALDEHYDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE P38; PARAFFIN; TRANSCRIPTION FACTOR RELA;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PAGET SKIN DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; CYCLINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PAGET'S DISEASE, EXTRAMAMMARY; SKIN NEOPLASMS; TRANSCRIPTION FACTOR RELA;

EID: 33846785453     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2006.12.003     Document Type: Article

References (30)

1. Hinz M., Krappmann D., Eichten A., Heder A., Scheidereit C., and Stranss M. NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol 19 (1999) 2690-2698
2. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., and Baldwin A.S. NF-κB controls cell growth ad differentiation through the transcriptional regulation of cyclin D1. Mol Cell Biol 19 (1999) 5785-5799
3. Davidson B., Konstantinovsky S., Kleinberg L., Nguyen M.T., Bassarova A., Kvalheim G., et al. The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma. Gynecol Oncol 102 (2006) 452-461
4. Shimada K., Nakamura M., Ishida E., and Konishi N. Molecular roles of MAP kinases and FADD phosphorylation in prostate cancer. Histol Histopathol 21 (2006) 415-422
5. Summy J.M., Trevino J.G., Baker C.H., and Gallick GE. c-Src regulates constitutive and EGF-mediated VEGF expression in pancreatic tumor cells through activation of phosphatidyl inositol-3 kinase and p38 MAPK. Pancreas 31 (2005) 263-274
6. Coltella N., Rasola A., Nano E., Bardella C., Fassetta M., Filigheddu N., et al. p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis. Int J Cancer 118 (2006) 2981-2990
7. Bang Y.J., Kwon J.H., Kang S.H., Kim J.W., and Yang Y.C. Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma. Biochem Biophys Res Commun 250 (1998) 43-47
8. Tsuboi Y., Ichida T., Sugitani S., Genda T., Inayoshi J., Takamura M., et al. Overexpression of extracellular signal-regulated protein kinase and its correlation with proliferation in human hepatocellular carcinoma. Liver Int 24 (2004) 432-436
9. Notari M., Neviani P., Santhanam R., Blaser B.W., Chang J.S., Galietta A., et al. A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation. Blood 107 (2006) 2507-2516
10. Lew J. MAP kinases and CDKs: kinetic basis for catalytic activation. Biochemistry 42 (2003) 849-856
11. Terada Y., Inoshita S., Nakashima O., Kuwahara M., Sasaki S., and Marumo F. Regulation of cyclin D1 expression and cell cycle progression by mitogen-activated protein kinase cascade. Kidney Int 56 (1999) 1258-1261
12. Ohnishi T., and Watanabe S. The use of cytokeratins 7 and 20 in the diagnosis of primary and secondary extramammary Paget's disease. Br J Dermatol 142 (2000) 243-247
13. Lloyd J., and Flanagan A.M. Mammary and extramammary Paget's disease. J Clin Pathol 53 (2000) 742-749
14. Fromowitz F.B., Viola M.V., Chao S., Oravez S., Mishriki Y., Finkel G., et al. Ras p21 expression in the progression of breast cancer. Human Pathol 18 (1987) 1268-1275
15. Zarubin T., and Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res 15 (2005) 11-18
16. Nakahara T., Moroi Y., Uchi H., and Furue M. Differential role of MAPK signaling in human dendritic cell maturation and Th1/Th2 engagement. J Dermatol Sci 42 (2006) 1-11
17. Ogawa T., Nagashima Y., Wada H., Akimoto K., Chiba Y., Nagatani T., et al. Extramammary Paget's disease: analysis of growth signal pathway from the human epidermal growth factor receptor 2 protein. Human Pathol 36 (2005) 1273-1280
18. Kawakami T., Soma Y., Mizoguchi M., and Saito R. Overexpression of transforming growth factor-beta3 immunohistochemical staining in extramammary Paget's disease, but downregulated expression in Bowen's disease. Int J Dermatol 40 (2001) 262-267
19. Karin M., Cao Y., Greten F.R., and Li Z.W. NF-kappa B in cancer. Nat Rev Cancer 2 (2002) 301-310
20. Karin M. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18 (1999) 6867-6874
21. Kuwahara I., Lillehoj E.P., Lu W., Singh I.S., Isohama Y., Miyata T., et al. Neutrophil elastase induces IL-8 gene transcription and protein release through p38/NF-κB activation via EGFR transactivation in a lung epithelial cell line. Am J Physiol Lung Cell Mol Physiol 291 3 (2006) L407-L416
22. Chandrasekar B., Valente A.J., Freeman G.L., Mahimainathan L., and Mummidi S. Interleukin-18 induces human cardiac endothelial cell death via a novel signaling pathway involving NF-kappaB-dependent PTEN activation. Biochem Biophys Res Commun 339 3 (2006) 956-963
23. Nevins J.R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 16 (1992) 424-429
24. Johnson D.G., Schwarz J.K., Cress W.D., and Nevins J.R. Expression of transcription factor E2F-1 induces quiescent cells to enter S phase. Nature 365 (1993) 349-352
25. Degregori J., Leone G., Ohtani K., Miron A., and Nevins J.R. E2F1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. Genes Dev 9 (1995) 2873-2887
26. Hinds P.W., Dowdy S.F., Eaton E.N., Arnold A., and Weinberg R.A. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 91 (1994) 709-713
27. Cordon-Cardo C. Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol 147 (1995) 545-560
28. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell 81 (1995) 323-330
29. Bartek J., Bartkova J., and Lukas J. The retinoblastoma protein pathway and the restriction point. Curr Opin Cell Biol 8 (1996) 805-814
30. Sherr C.J. Cancer cell cycles. Science 274 (1996) 1672-1677